Brian Baranick - Apr 30, 2024 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Signature
/s/ Brian Baranick by Mark R. Busch, attorney-in-fact
Stock symbol
EXAS
Transactions as of
Apr 30, 2024
Transactions value $
-$6,617
Form type
4
Date filed
5/2/2024, 07:00 PM
Previous filing
Apr 3, 2024
Next filing
Aug 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Award $0 +218 +1.66% $0.00 13.4K Apr 30, 2024 Direct F1, F2
transaction EXAS Common Stock Sale -$6.62K -110 -0.82% $60.15 13.3K May 1, 2024 Direct F2, F3
holding EXAS Common Stock 454 Apr 30, 2024 Held in 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents additional shares of common stock received upon settlement of a performance share unit award on April 30, 2024.
F2 In addition to the shares of Common Stock reported on this Form 4, which total 13,733 shares, Mr. Baranick also holds, in the aggregate, an additional 46,318 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
F3 Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units.